Analystreport

Deciphera Pharmaceuticals, Inc. (NASDAQ: DCPH) had its "hold" rating re-affirmed by analysts at Jonestrading. They now have a $25.60 price target on the stock.

Deciphera Pharmaceuticals, Inc.  (DCPH) 
Last deciphera pharmaceuticals, inc. earnings: 3/9 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: deciphera.com/investor-relations